Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · Real-Time Price · USD
8.68
+0.62 (7.69%)
Nov 9, 2026, 11:27 AM EST - Market open
Immix Biopharma Market Cap
Immix Biopharma has a market cap or net worth of $719.6 million as of November 9, 2026. It is the 12,405th most valuable company in the world and the 2,508th biggest in the United States. Its market cap has increased by 580.34% in one year.
Market Cap
719.60M
Enterprise Value
488.49M
1-Year Change
580.34%
Global Rank
Country Rank
#2,508 United States
Category
ChartMarket Cap Chart
Since the IPO on December 16, 2021, Immix Biopharma's market cap has increased from $65.74M to $719.60M, an increase of 994.55%. That is a compound annual growth rate of 62.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 9, 2026 | 719.60M | 161.10% |
| Dec 31, 2025 | 275.60M | 355.41% |
| Dec 31, 2024 | 60.52M | -55.98% |
| Dec 29, 2023 | 137.48M | 331.07% |
| Dec 30, 2022 | 31.89M | -32.18% |
| Dec 31, 2021 | 47.02M | -28.48% |
| Dec 16, 2021 | 65.74M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Achieve Life Sciences | 691.50M |
| Zevra Therapeutics | 689.66M |
| Aura Biosciences | 680.30M |
| 4D Molecular Therapeutics | 676.74M |
| ArriVent BioPharma | 672.56M |
| Candel Therapeutics | 669.54M |
| Wave Life Sciences | 663.68M |
| Adlai Nortye Group | 662.01M |